Multi-Omics Technologies for Singapore Single Cell Have Emerged

Development of single cell multi-omics analysis has enabled cell type specific gene regulation to be examined. Recent advancements in single cell isolation and barcoding technologies can typically measure multiple kinds of molecules from the same individual cell. They offer in-depth biological insight by analyzing each molecular layer from separate cells.

According to a report published by Allied Market Research, the global single cell multi-omics market size is registered to reach $15.2 billion with a considerable CAGR from 2021 to 2030. Certain factors such as rise in disposable income in emerging economies, surge in number of large scale genomics studies, technological advancements in single cell analysis products, and increase in adoption of personalized medicine for screening & diagnostics of genetic disorders are driving the growth of the market in more than one way.

Request for Sample Report for More Insights @ https://www.alliedmarketresearch.com/request-sample/12148

Top Leading Players:

· 10x Genomics, Inc.

· Becton, Dickinson and Company

· Berkeley Lights Inc

· BGI Genomics Co. Ltd

· Bio Rad Laboratories, Inc.

· Danaher Corporation (Cytiva Life Sciences)

· Dolomite Bio

· Epicypher Inc.

· Fluidigm Corporation

· Illimina, Inc

· Miltenyi Biotec B.V. & CO.

· Mission Bio, Inc.

· Nanostring Technologies, Inc

· Olink Holding AB (Olink Proteomics)

· Parse Bioscience

· Qiagen N.V.

· Takara Holdings Inc. Takara Bio Group

· Thermo Fisher Scientific, Inc.

Covid-19 Scenario-

However, the outbreak of the COVID-19 pandemic led to have a negative impact on the global single cell multi-omics market. It is due to the fact that almost all clinics & hospitals across the world were restructured to expand the hospital capacity for COVID-19 patients. Most of the non-essential medical procedures were either canceled or postponed, especially in the initial period. This in turn, caused disruption in the healthcare system. On top of that, factors such as distorted supply chain, limited availability of medical care, and shortage of healthcare experts created several challenges in the healthcare sector.

Nevertheless, North America is currently holding the highest market share, owing to availability of developed healthcare infrastructure and continuous R&D activities for the development of advanced technologies in the developed countries like the U.S., Canada, and others. At the same time, Europe is anticipated to witness the fastest growth rate, attributed to massive growth opportunities in Germany and UK.

With this drift on board, the key market players are adopting new strategies to stay competitive in the market. A significant rise in multiple initiatives, surge in funding in single cell multiomics research, partnerships & collaborations among pharmaceutical & biotechnological enterprises and so many other factors have boosted the growth of the global single cell multi-omics market to a great extent. Here, it is worth mentioning that the global single cell multi-omics market has a huge scope to gather immense growth in the years to come.